Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TGFβ2 is a Prognostic Biomarker for Gastric Cancer and is Associated With Methylation and Immunotherapy Responses. | Front Genet | 2022 | 35620459 | PubTator, text mining | PubMed |
| Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies. | Nat Immunol | 2022 | 35618834 | PubTator, text mining | PubMed |
| Crosstalk between IL-15Rα+ tumor-associated macrophages and breast cancer cells reduces CD8+ T cell recruitment. | Cancer Commun (Lond) | 2022 | 35615815 | PubTator, text mining | PubMed |
| Exhaustion of CAR T cells: potential causes and solutions. | J Transl Med | 2022 | 35606821 | PubTator, text mining | PubMed |
| Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes. | Front Immunol | 2022 | 35603204 | PubTator, text mining | PubMed |
| Predicting T-cell quality during manufacturing through an artificial intelligence-based integrative multiomics analytical platform. | Bioeng Transl Med | 2022 | 35600660 | PubTator, text mining | PubMed |
| Selective Targeting of IL-15Rα Is Sufficient to Reduce Inflammation. | Front Immunol | 2022 | 35592318 | PubTator, text mining | PubMed |
| T cell help in the autoreactive germinal center. | Scand J Immunol | 2022 | 35587582 | PubTator, text mining | PubMed |
| Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells. | J Immunother Cancer | 2022 | 35580928 | PubTator, text mining | PubMed |
| An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease. | Nat Commun | 2022 | 35577777 | PubTator, text mining | PubMed |
| Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer. | Front Immunol | 2022 | 35572581 | PubTator, text mining | PubMed |
| Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression. | Cancers (Basel) | 2022 | 35565467 | PubTator, text mining | PubMed |
| Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls. | Front Psychiatry | 2022 | 35546954 | PubTator, text mining | PubMed |
| Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. | Nat Commun | 2022 | 35534471 | PubTator, text mining | PubMed |
| Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives. | Front Immunol | 2022 | 35529882 | PubTator, text mining | PubMed |
| The Yin and Yang of Pneumolysin During Pneumococcal Infection. | Front Immunol | 2022 | 35529870 | PubTator, text mining | PubMed |
| Convergent evolution of a parasite-encoded complement control protein-scaffold to mimic binding of mammalian TGF-β to its receptors, TβRI and TβRII. | J Biol Chem | 2022 | 35500648 | PubTator, text mining | PubMed |
| A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies. | Front Immunol | 2022 | 35493522 | PubTator, text mining | PubMed |
| Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma. | Front Immunol | 2022 | 35493471 | PubTator, text mining | PubMed |
| Systematic molecular analysis of the human secretome and membrane proteome in gastrointestinal adenocarcinomas. | J Cell Mol Med | 2022 | 35488454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=29